Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FCX | Common Stock | Options Exercise | $562K | +30K | +18.29% | $18.74 | 194K | Apr 29, 2024 | Direct | |
transaction | FCX | Common Stock | Options Exercise | $297K | +25K | +12.88% | $11.87 | 219K | Apr 29, 2024 | Direct | |
transaction | FCX | Common Stock | Sale | -$2.86M | -55K | -25.11% | $51.99 | 164K | Apr 29, 2024 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FCX | Options (Right to Buy) | Options Exercise | $0 | -30K | -100% | $0.00* | 0 | Apr 29, 2024 | Common Stock | 30K | $18.74 | Direct | F3 |
transaction | FCX | Options (Right to Buy) | Options Exercise | $0 | -25K | -50% | $0.00 | 25K | Apr 29, 2024 | Common Stock | 25K | $11.87 | Direct | F3 |
Id | Content |
---|---|
F1 | The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $51.9400 - $52.0250. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
F2 | Amount beneficially owned includes 38,000 Restricted Stock Units. |
F3 | 33% exercisable on the date indicated and 33% exercisable on each of the next two anniversaries thereof. |